Related Experiment Video

Updated: Mar 17, 2026

Microfluidics in Assessing Platelet Function
06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

1.8K

Relationship between platelet-leukocyte aggregation and myocardial perfusion in patients with ST-segment

Guang-Yong Huang1, Lan-Ju Yang1, Xiao-Hua Wang1

  • 1Department of Cardiology, Liaocheng People's Hospital, Liaocheng Clinical School of Taishan Medical University, Liaocheng 252000, Shandong, China.

Heart & Lung : the Journal of Critical Care
|July 19, 2016
PubMed

Insights

Inflammation and oxidative stress are linked to poor myocardial perfusion in ST-segment elevation myocardial infarction (STEMI) patients post-primary percutaneous coronary intervention (PCI). Higher neutrophil ratios and platelet aggregation correlate with worse outcomes.

Area of Science:

  • Cardiology
  • Biomedical Science
  • Medical Research

Background:

  • Mechanisms underlying poor reperfusion after primary percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI) require further elucidation.
  • Understanding these mechanisms is crucial for improving patient outcomes following acute myocardial infarction.

Purpose of the Study:

  • To investigate the association between inflammation, oxidative stress, and myocardial perfusion.
  • To identify risk factors contributing to suboptimal reperfusion in STEMI patients undergoing primary PCI.

Main Methods:

  • 143 STEMI patients undergoing primary PCI were categorized into good and poor perfusion groups based on sum-ST-segment resolution (sumSTR) and TIMI myocardial perfusion grade (TMP).
  • Blood samples were analyzed for platelet aggregation (platelet-leukocyte aggregation [PLA], platelet-neutrophil aggregation [PNA], platelet-monocyte aggregation [PMA], platelet-lymphocyte aggregation [PLyA]) and oxidative stress markers (malondialdehyde [MDA], superoxide dismutase [SOD]).

Main Results:

  • The poor perfusion group exhibited significantly higher leukocyte counts, neutrophil ratios, high-sensitivity C-reactive protein, PLA, PNA, PMA, and MDA levels.
  • Neutrophil ratio was identified as an independent risk factor for sumSTR in STEMI patients post-primary PCI.
  • No significant differences in PLyA or SOD levels were observed between the groups.

Conclusions:

  • Inflammation and oxidative stress are significantly related to poor myocardial perfusion in STEMI patients after primary PCI.
  • Elevated markers of inflammation and platelet-leukocyte aggregation contribute to impaired myocardial reperfusion.
Abstract

Keywords:
InflammationMyocardial infarctionMyocardial reperfusionOxidative stressPlatelet-leukocyte aggregation

More Related Videos

Platelet Adhesion and Aggregation Under Flow using Microfluidic Flow Cells10:10

Platelet Adhesion and Aggregation Under Flow using Microfluidic Flow Cells

Published on: October 27, 2009

18.7K
Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

9.8K

Related Concept Videos

Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
10.4K
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.4K
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
405
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
637
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.5K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
384